F19.951

Clinical Causes: Use of multiple or unspecified psychoactive substances such as stimulants, depressants, or hallucinogens. Prolonged or high-dose substance use leading to changes in brain chemistry. Pre-existing mental health conditions that may increase susceptibility. Genetic factors influencing individual response to psychoactive substances. Environmental stressors or triggers that may contribute to substance misuse.

Key Symptoms: Hallucinations, which may involve seeing, hearing, or feeling things that are not present. Altered perception of reality, including confusion or disorganized thinking. Behavioral changes such as agitation, paranoia, or aggression. Physical symptoms such as increased heart rate, sweating, or tremors. Possible mood swings or emotional disturbances.

Diagnosis Path: Diagnosis involves psychiatric evaluation and assessing the individual's history of substance use. Medical professionals may conduct physical and neurological examinations, laboratory tests to detect substances, and psychiatric assessments to evaluate the presence and severity of psychotic symptoms. Proper diagnosis helps differentiate between substance-induced psychosis and other mental health disorders.

Treatment Protocols: Treatment strategies typically include: - Substance cessation support, which may involve detoxification programs. - Pharmacological interventions to manage psychotic symptoms, such as antipsychotic medications. - Psychotherapy approaches including cognitive-behavioral therapy (CBT) to address underlying issues and prevent relapse. - Supportive care and counseling to help individuals develop coping strategies. - Long-term follow-up to monitor mental health and prevent recurrence. Each treatment plan is personalized based on the individual’s specific needs and severity of symptoms.